Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
News Release Digital Asset Direct

Agile Therapeutics Partners with Carli Lloyd, U.S. Women’s Soccer Star and Four-Time Olympian, to Bring Awareness to Women’s Health Topics

Agile Therapeutics

Agile Therapeutics, Inc. (Nasdaq: AGRX ), a women's healthcare company, announced today a partnership with U.S. Women’s Soccer legend, Carli Lloyd. The partnership with Agile will focus on bringing awareness to women’s health topics, and Agile’s commitment to elevating women’s healthcare. Lloyd, who will play her final game for the U.S. Women’s National Team on October 26 th against South Korea, was attracted to the company’s mission of addressing the healthcare needs of today’s women. “I’m excited to be partnering with a company solely dedicated to women’s health,” said Lloyd. “I aim to work with organizations that focus on things I care about, and staying healthy has been a priority for my career on the field and will continue to be so as I look ahead to my next chapter. Agile’s focus on bringing women options and knowledge when it comes to their healthcare decisions is a mission I’m proud to be part of. And the fact that I’m a Jersey girl, representing a New Jersey company makes it even better.” Agile has built its brand around a commitment to addressing women’s health needs. It received approval from the U.S. Food and Drug Administration (FDA) in February 2020 for its first product, Twirla ® (levonorgestrel and ethinyl estradiol) transdermal system, a weekly contraceptive patch. It currently has four additional contraceptive products in its pipeline. “Carli’s ‘ always believe and never quit ’ attitude fits what Agile Therapeutics believes as a company,” said Al Altomari, CEO of Agile Therapeutics. “We’ve been selective about aligning with the right partners at the right time, and Carli is someone who seamlessly fits our corporate culture, aligns with our values, and understands the importance of empowering women, especially young women, to reach beyond their limits, believe in themselves, and never compromise, especially with their healthcare.” As a growing company, Agile sees this partnership as an opportunity to help further develop its culture and corporate brand by partnering with leaders who share the company’s values and mission.. “Our short-term goal is to establish Twirla in the contraceptive market, and our long-term mission remains the same: Build a robust women’s health franchise, and Carli is a critical piece of that puzzle,” said Altomari. “She’s been a vocal advocate for women, and her voice is an important one in the national conversation about women’s health and healthcare needs. We want to be sure we communicate our message and commitment to women’s health in an authentic and relatable way. This is a mission we share with Carli, and we are proud to welcome her to our team.” About Agile Therapeutics, Inc. Agile Therapeutics is a women's healthcare company dedicated to fulfilling the unmet health needs of today’s women. Our product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Our initial product, Twirla®, (levonorgestrel and ethinyl estradiol), a transdermal system, is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com. The Company may occasionally disseminate material, nonpublic information on the Company’s website. About Twirla® Twirla (levonorgestrel and ethinyl estradiol) transdermal system is a once-weekly combined hormonal contraceptive (CHC) patch that contains the active ingredients levonorgestrel (LNG), a type of progestin, and ethinyl estradiol (EE), a type of estrogen. Twirla is indicated for use as a method of contraception by women of reproductive potential with a body mass index (BMI) < 30 kg/m2 for whom a combined hormonal contraceptive is appropriate. Healthcare providers (HCPs) are encouraged to consider Twirla’s reduced efficacy in women with a BMI ≥ 25 to <30 kg/m2 before prescribing. Twirla is contraindicated in women with a BMI ≥ 30 kg/m2. Twirla is contraindicated in women over 35 years old who smoke. Cigarette smoking increases the risk of serious cardiovascular events from CHC use. Twirla is designed to be applied once weekly for three weeks, followed by a week without a patch. Contact Details Matt Riley, Head of Investor Relations and Corporate Communications mriley@agiletherapeutics.com Company Website https://agiletherapeutics.com

September 28, 2021 02:52 PM Eastern Daylight Time

Data Show New Kidney and Liver Policies Expand Access, Equity

United Network for Organ Sharing

New liver and kidney allocation policies have expanded equitable access to lifesaving organs for patients on the national waitlist, according to data analysis from United Network for Organ Sharing (UNOS), which serves as the nation’s transplant system under federal contract. UNOS leadership presented this data for members of Congress during a virtual briefing today. Changes to the liver allocation policy went into effect in February of 2020 and the kidney allocation policy followed a year later, in March of 2021. Recent monitoring report data show the liver and kidney policies have so far resulted in more transplants overall while also reducing disparities in access based on where a patient is listed. Liver transplants increased by 3 percent and kidney transplants increased by 16 percent, even in the midst of the COVID-19 pandemic. This is in keeping with the high performance of the national donation and transplantation system, which marked the eighth year of growth in deceased donor transplants in 2020 despite the ongoing global health crisis. “These policies expand equitable access to lifesaving organs,” said UNOS CEO Brian Shepard. “We continue to make progress through robust policy development, improving the highest performing organ donation and transplantation system in the world.” The 15-month liver monitoring report shows that the policy is performing as intended. More organs are going to the sickest patients, especially adults with the most medically-urgent needs, regardless of where they are listed for transplant. Early monitoring data of the circles-based model for kidney allocation indicate that it has also contributed to broadened equity. A new report containing key measures of the first full two-months of enactment show an increase in kidney transplants for children, ethnic and racial minorities, moderately hard-to-match patients and those with longer dialysis times. More than 400 donation and transplant professionals, donor family members and patients nationwide helped develop the new policies. “The results of the new kidney and liver policies are a testament to our community’s ability to unify a diverse membership around the shared goal of saving lives,” said UNOS Board President Matt Cooper, M.D., Director of Pancreas and Kidney Transplantation at MedStar Georgetown Transplant Institute, and professor of surgery at Georgetown University School of Medicine. “Even during a pandemic, we saw a resilient system not only rebound, but formalize, enact, and monitor two effective allocation policies. UNOS is the engine that powers this complex process, and we remain focused on building on our successes while continuing to address ongoing challenges.” To learn more about UNOS’ policy development process, click here. ### About United Network for Organ Sharing (UNOS) is a non-profit, charitable organization that serves as the Organ Procurement and Transplantation Network (OPTN) under contract with the federal government. The OPTN helps create and define organ allocation and distribution policies that make the best use of donated organs. This process involves continuously evaluating new advances and discoveries so policies can be adapted to best serve patients waiting for transplants. All transplant programs and organ procurement organizations throughout the country are OPTN members and follow the policies the OPTN creates for allocating organs. Contact Details Anne Paschke +1 804-782-4730 anne.paschke@unos.org Company Website https://unos.org

September 28, 2021 12:18 PM Eastern Daylight Time

BreatheSuite Receives FDA Clearance for Over-the-Counter Device to Turn Regular Metered-Dose Inhalers into Smart Inhalers

BreatheSuite

BreatheSuite Inc., a Canadian connected respiratory health company, today announced that it has received 510(K) clearance from the U.S. Food and Drug Administration (FDA) for its BreatheSuite Metered-Dose Inhaler (MDI) V1 device. Approved for both prescription and over-the-counter use, the BreatheSuite device turns existing MDIs into smart inhalers by automatically and objectively monitoring and providing feedback on inhaler adherence and technique for people with asthma and COPD. Tens of millions of Americans currently use MDIs. Techniques such as shaking the MDI 10-15 times, as well as breath timing and positioning, can greatly impact the amount of medication that reaches the lungs. For every 100 people who use an inhaler, 90 are using it incorrectly; 66 are not adherent to the medication as prescribed (skipping doses, etc.). Inhaler misuse makes up about $5- $7 billion of the approximately $25 billion spent on inhalers annually. The BreatheSuite System – composed of a disposable, battery-powered, portable BreatheSuite MDI add-on device and a mobile application based on behavior change strategies – is designed to work with an MDI by attaching to the top of the canister of the patient’s inhaler. The device and mobile app work together to evaluate and “score” a person’s inhaler technique and usage patterns, storing results in the cloud so the person can track and use this information to improve how they use their inhaler. With consent, this information can also be remotely monitored by the person’s healthcare team to promote customizable care plans. By promoting more effective inhaler use and remote patient monitoring (RPM), BreatheSuite aims to improve quality of care and health outcomes while reducing the economic burden associated with these conditions. Medical costs for chronic COPD were estimated to reach $49 billion in 2020, and the annual economic cost of asthma from 2008-2013 was more than $81.9 billion – with medical costs alone accounting for $50.3 billion. “We are extremely excited to have obtained FDA clearance, which is a critical step in achieving our vision of improving the lives of respiratory patients worldwide,” said Brett Vokey, Founder and CEO of BreatheSuite. “The COVID-19 pandemic has underscored that now is the time for remote patient monitoring to take a front seat in providing better, more transparent care for all people with asthma or COPD. With FDA clearance, we are poised to become a leader in providing actionable insights to people with asthma or COPD across the United States.” “By having a real-time way to digitally monitor and provide feedback to patients, we hope to enhance healthcare outcomes,” said Dr. Meshari F. Alwashmi, Chief Scientific Officer, BreatheSuite. “Furthermore, having an objective measure of adherence and technique from each user with asthma and COPD will advance the sphere of knowledge regarding the effectiveness of inhaled medications.” The BreatheSuite device does not interfere with regular MDI usage and can be removed and reattached to a new inhaler with ease. The device is compatible with 90% of MDIs on the market, including those manufactured by GlaxoSmithKline (GSK), Teva and Prasco. In addition to FDA clearance, which is a first for a Newfoundland and Labrador-based company, the BreatheSuite device has also been cleared for sale in Canada. About BreatheSuite BreatheSuite is a Canadian connected health company founded in 2018 to help people with chronic respiratory conditions live longer, healthier lives. The BreatheSuite MDI device is designed to track and train proper inhaler usage, while the BreatheSuite App applies behavior change tactics to improve adherence, and tips on how to improve inhaler technique. BreatheSuite works with leading partners across North America to deliver better care to people with chronic respiratory conditions. For more information visit www.breathesuite.com or contact info@BreatheSuite.com. Contact Details SVM Public Relations and Marketing Communications Jordan Bouclin +1 401-490-9700 jordan.bouclin@svmpr.com Company Website https://www.breathesuite.com/

September 28, 2021 10:00 AM Eastern Daylight Time

Image

Minuteman Press Bethesda Partners with In America Flags to Remember COVID-19 Victims

Minuteman Press International Inc

In America: Remember is a public art exhibition being held at the National Mall that displays 660,000 white flags to honor the people in America who have been lost due to COVID-19. Minuteman Press in Bethesda, Maryland, is a partner for the exhibition, providing printed message cards from people all over the country who are paying tribute to loved ones through the In America website. “We are glad to be able to do our part to help this art exhibition,” says Leslie Klein, owner, Minuteman Press, Bethesda. “Every day, we receive all of the messages that were submitted through the In America website and we print them 8 up on 11 x 17 sheets to create 4.25 x 5.5 cards. Every night, I drop off the finished cards to one of the volunteers, and then they are transcribed onto the flags by another group of volunteers.” Leslie adds, “This is a total team effort and we are proud to be partners in such an important and moving exhibition. Our hearts go out to those who have been lost and their families.” The In America: Remember exhibition was designed by artist Suzanne Brennan Firstenberg. The exhibition is open for public participation now through October 3 rd, 2021. Hours are Weekdays from 10 AM – Sunset and Weekends from 9 AM – Sunset. For more information, visit https://www.inamericaflags.org. Minuteman Press in Bethesda is located at 8210 Wisconsin Ave., Bethesda, MD 20814. For more information, call 301-656-1188 or visit their website: https://minuteman.com/us/locations/md/bethesda Learn more about Minuteman Press products and services at https://minuteman.com Contact Details Minuteman Press International Chris Biscuiti +1 631-249-1370 cbiscuiti@mpihq.com Company Website https://minutemanpressfranchise.com

September 28, 2021 10:00 AM Eastern Daylight Time

Image

CMS Awards Medicare Pricing and Coding Services Contract to Bellese Technologies

Bellese Technologies, LLC

The Centers for Medicare & Medicaid Services (CMS) recently awarded Bellese Technologies the Medicare Payment System Modernization (MPSM) Pricing and Coding Services (PCS) contract. For the past three years, Bellese has worked with CMS, the United States Digital Service (USDS), and stakeholders in the MPSM ecosystem to incrementally modernize the decades-old, mainframe-based legacy payment systems. The Pricing and Coding Services contract is a continuation of the claims pricing modernization work that Bellese accomplished on the preceding contract and includes new work for claims grouping and coding services. Medicare claims payment determination takes numerous variables into consideration, such as fee schedules, price calculations, geographic location, provider type, and payment model participation. The Pricing and Coding Services contract is part of CMS’ holistic approach to give responsive, correct, and accessible services to providers and vendors who support the claims submission process. The modern services will support CMS’ ability to quickly accommodate policy changes and initiatives that determine claims prices. “We’ve been fortunate to be an MPSM pioneer in the application of user research, product management, service design, and the build-out of a cloud-based architectural runway required to support the modern pricer tools,” said Pam Offutt, Bellese Partner and CEO. “Our goal is to give CMS the flexibility they need to quickly provide accurate pricing and coding services to the Medicare community.” John duClos, Bellese Partner and CTO, added that, “the use of a global API specification and a common component strategy contributed to the progressive conversion and modernization of the pricer product. We are excited to build on our success and grateful to continue this important legacy system modernization work with CMS.” ABOUT BELLESE TECHNOLOGIES: Founded in 2009, Bellese Technologies is a human-centered service design company in the Baltimore metro area. Bellese partners with health and human services clients in the public and private sectors. The firm leverages modern technology, human-centered design, and silo-busting collaboration to help its clients expand and accelerate the positive impact they have on society. Currently, Bellese works with the Centers for Medicare & Medicaid Services, supporting price transparency, Medicare payment system modernization, and quality of care initiatives. Bellese holds the GSA IT 70 Schedule and two CMS agile blanket purchase agreements (BPA) — the Medicare Payment System Modernization (MPSM) BPA and the Agile Delivery to Execute Legislative Endeavors-Quality Related Initiatives (ADELE-QRI) BPA. Bellese has been recognized numerous times as a “Top Workplace” by the Baltimore Sun. Visit bellese.io/careers for information on open positions at Bellese. Contact Details Bellese Technologies Shelley Gold, Vice President Client Relations & Growth Strategy +1 410-486-6800 press@bellese.io Company Website https://bellese.io/

September 28, 2021 09:00 AM Eastern Daylight Time

R2 Technologies’ Novel Glacial Rx® System Earns Third FDA Indication and Unique Product Code

R2 Technologies

R2 Technologies Inc. ("R2"), the leader in CryoAesthetic™ medical devices, announces that its revolutionary in-office system, Glacial Rx®, FDA-cleared to remove benign lesions and temporarily reduce pain, swelling and inflammation, is now the first and only dermal cooling system FDA-cleared for general dermabrasion, scar and acne scar revision, and tattoo removal, permanently changing the aesthetics industry. “This additional FDA clearance is a huge win, and not an easy feat. It took innovation, dedication, time, and resources,” says Tim Holt, R2 Chief Executive Officer. “It couldn’t have been possible without our amazing team and strategic partners. The clearance had an exceptional outcome in which we went from being part of one classification, among hundreds of other devices, to being placed in our very own FDA-issued product code. This is further proof that our product is so novel, it warrants a completely new category.” “R2 has been at the forefront of the med-esthetics space since inception with its unmatched technology and continues to lead advancements in the industry. We are excited to see the company break boundaries yet again with its latest indication,” says David Present, MD and Cherine Eldumiati Plumaker, R2’s Chairman and Vice Chairman respectively. In conjunction with the commercial launch, R2 looked within its remarkable team of industry veterans, including the inventors of the Glacial Rx technology, Rox Anderson, MD; Dieter Manstein MD, PhD; and Henry Chan, MD, PhD, to create its newly established Scientific Advisory Board. By continuing to have these highly regarded pioneers as an integral part of the company, R2 stands out amongst the competitive medical aesthetics market as an industry frontrunner. “With the appointment of our new Scientific Advisory Board, R2 is tapping into years of knowledge and expertise to launch new groundbreaking innovations, develop a superior product pipeline, and leverage technical insights to secure new clinical indications and expansion opportunities,” says Holt. Launched in March 2021, Glacial Rx’s presence in the U.S. has grown significantly. R2 is continuing to take orders from aesthetic providers who want to offer this revolutionary treatment in-office. To learn more about R2, treatment offerings and providers, visit glacialskin.com and follow the company on LinkedIn. About R2 Technologies Headquartered in Silicon Valley, with a recent expansion in Florida and new Miami-based satellite office, R2 Technologies is a world leader in CryoAesthetic™ medical devices. In 2014, Pansend Life Sciences, LLC and Blossom Innovations, LLC founded R2 Technologies and licensed exclusive intellectual property from Massachusetts General Hospital and Blossom Innovations. In 2019, R2 brought on strategic partner, Huadong Medicine Co., Ltd. In close collaboration with these partners and the brand’s scientiﬁc founders and world-famous luminaries in aesthetic medicine, Drs. Rox Anderson, Dieter Manstein, and Henry Chan, R2 focuses on the development, engineering, clinical research, and commercialization of groundbreaking technologies for aesthetic providers and consumers. Its first innovation, Glacial Rx, was named one of the ‘2021 Launches Doctors are Buzzing About’ by RealSelf, the leading, most trusted source to educate on cosmetic procedures. R2 also won the 2nd Annual Aesthetics Tech Summit LaunchPad SBDC, hosted by Octane, a company committed to making resources, capital, and mentorship available to tech startups. Since inception, R2 has raised $76M in ﬁnancing. Contact Details Linsey Tilbor Rubin +1 732-991-5294 ltilbor@rellmc.com Company Website https://glacialskin.com/

September 28, 2021 08:33 AM Eastern Daylight Time

D8.co to Launch 1-Hour Delivery for Delta-8 THC Products

D8 Holdings, Inc.

D8.co the market leader in hemp-derived Delta-8 THC —today announced it is launching 1-hour delivery for consumer orders throughout the United States. D8.co will deliver their award winning Delta-8 carts, Delta-8 disposables, and Delta-8 gummies to any customer within 1-hour in a 25-mile radius of any professional NFL team. Outside that radius customers will receive next day packages at the latest. “The largest problem we have is fulfillment and delivery,” said Chris Duffield, CEO of D8.co. “Anyone shipping consumer goods knows that all the carriers are a current nightmare. We have shipped thousands of packages priority and the majority show up two or three days late, with far too many getting lost or stolen. If a customer places an order after cutoff on Friday, they have to wait an additional three days. Customers want our products, and they want them immediately.” The first six states D8.co will integrate into their program are Texas, Georgia, Florida, Minnesota, Ohio, and North Carolina. The company will expand into the rest of the U.S immediately, with full integration expected to take approximately 45 days. “We have more than 50 major fulfillment centers locked in that are centrally managed from our cloud technology. Once an order is placed, our customers will receive an email and text where they can track our drivers all the way to delivery,” said Hugh McPherson, EVP of D8.co. D8.co expects to immediately double online sales with the new integration. “We are extremely excited to launch 1-hour delivery,” said Duffield. “We just became the largest cannabis company in the United States, which makes us a prime acquisition target. I’m very proud of our core team and all the hard work everyone has put in to make D8 the number one brand in the market.” About D8.co D8.co is based in Colorado and Miami with satellite offices in Las Vegas and Los Angeles. The company is an assembly of the top hemp and cannabis minds in the country. With backgrounds in extraction, chemistry, manufacturing, marketing, distribution, and legal, the D8 team came together organically around this elusive, but extremely powerful molecule to create a new category of products. More info at www.d8.co. Contact Details D8.co Chris Duffield +1 424-333-2112 chris@d8.co Company Website https://d8.co/

September 23, 2021 12:26 PM Eastern Daylight Time

The State of Our Schools: The Nation’s Public School Facilities in Crisis

YourUpdateTV

A video accompanying this announcement is available at: https://youtu.be/g7dJiz_7fRI Living through a pandemic has heightened the awareness for many parents around the issues of health and safety in the schools their children attend. As school districts across the U.S. prepare for and begin a new academic year, the International WELL Building Institute (IWBI), along with 21 st Century School Fund and the National Council on School Facilities, is releasing a new report that takes a comprehensive look into the current state of our nation’s school facilities funding and draws attention to the disparity across the U.S. in funding efforts. Ending disparities in facilities conditions and quality by income, locale and race, must be prioritized as these gaps will not be closed without an aggressive and an intentional plan to eliminate them. IWBI is working to ensure the health, safety, education suitability, and environmental sustainability and resilience for our students, teachers and staff now and for the future. The 2021 State of Our Schools Report puts a white-hot spotlight on the fact that severe and chronic underinvestment – to the tune of $85 billion a year – is eroding the country’s ability to provide safe, healthy and sustainable schools. Every day, nearly 60 million people—students, teachers and staff—walk through the doors of our country’s nearly 100,000 PK-12 public schools, which represent the second largest sector of U.S. public infrastructure spending after highways. States and local school districts do their best to increase their efforts to maintain and invest in their school facilities when funding is available, but they are falling further and further behind. For more information visit: wellcertified.com About The International WELL Building Institute: The International WELL Building Institute (IWBI) is a public benefit corporation and the world’s leading organization focused on deploying people first places to advance a global culture of health. IWBI mobilizes its community through the administration of the WELL Building Standard (WELL) and the WELL Health-Safety Rating, management of the WELL AP credential, the pursuit of applicable research, the development of educational resources, and advocacy for policies that promote health and well-being everywhere. More information on WELL can be found here. International WELL Building Institute, IWBI, the WELL Building Standard, WELL v2, WELL Certified, WELL AP, WELL Portfolio, WELL Portfolio Score, The WELL Conference, We Are WELL, the WELL Community Standard, WELL Health-Safety Rating, WELL Health-Safety Rated, WELL Health-Equity, WELL Performance Rating, WELL Performance Rated, WELL Performance, WELL and others, and their related logos are trademarks or certification marks of International WELL Building Institute pbc in the United States and other countries. About YourUpdateTV: YourUpdateTV is a social media video portal for organizations to share their content. It includes separate channels for Health and Wellness, Lifestyle, Media and Entertainment, Money and Finance, Social Responsibility, Sports and Technology. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

September 23, 2021 09:08 AM Eastern Daylight Time

Video

CHAPTER AESTHETIC STUDIO LAUNCHES SECOND LOCATION WITH NEW STUDIO IN NEW HARTFORD, NY

Aspen Dental

CHICAGO, Ill. — Chapter Aesthetic Studio, a leading aesthetic studio providing evidence-based, non-surgical cosmetic treatments, has officially opened its doors in New Hartford, NY with the acquisition of Alivana Aesthetics, bringing a new look to the office and introducing new services along with a line of pharmaceutical-grade skincare products. This is the second location, of 12 planned in the next year, for the recently launched national brand of state-of-the-art, medical aesthetic clinics. Chapter Aesthetic Studio was launched in 2021 by Aspen Dental Management, Inc. (ADMI) and Rejuv Medical Aesthetic Clinic in an effort to create a new national brand of medical aesthetic clinics, taking an evidence-based approach to create personalized treatment plans that deliver measurable results. As one of ADMI’s health care brands, Chapter Aesthetic Studio has access to specialized real estate, operations, marketing, recruiting and training services. All of this helps Chapter’s providers focus on delivering best-in-class service and personalized care to their guests. “We continue to transform the medical aesthetic industry with this second location in New Hartford,” said Melissa Rogne, Founder & President of the Chapter Aesthetic Studio. “We’re excited to serve the New Hartford community and keep our momentum of expanding nationwide.” To celebrate the relaunch, Chapter Aesthetic Studio will host The Autumn Exclusive event on Thursday, September 30 th from 4-8 p.m., featuring treatment demonstrations and giveaways. The New Hartford Chapter Aesthetic Studio office is also holding its biggest sale of the year in September – guests can save up to 30% from September 9 th through September 30th on all products and services. Located at 4626 Commercial Drive New Hartford, NY 13413, the office is led by owner and managing clinical director Jennifer Baldwin, an American Association of Nurse Practitioners (AANP)-certified Nurse Practitioner with more than 20 years of experience in patient health and wellness. Baldwin and her team will provide a full range of customized cosmetic treatments, including: Injectables: Injectables are a common way to relax wrinkles and fine lines, or plump areas where skin or lips have lost volume. Chapter’s specialists are skilled in the science of cosmetic injectables — and the art of listening. Chapter offers popular injectable brands including, Botox®, Dysport®, Xeomin®, Juvéderm®, RHA® and Kybella®, as well as thread lift and PRFM treatments. Laser Treatments: Lasers are a safe and clinically proven way to enhance skin health and appearance and treat common concerns. The Chapter team is highly skilled in industry-leading and scientifically advanced laser technologies, giving patients a variety of treatment options to safely and effectively deliver remarkable results. Treatment options include laser hair removal, IPL Photofacial and Morpheus8. Aesthetic Treatments: Patients can look and feel rejuvenated than with Chapter’s medical-grade facials, microneedling treatments and exfloitating peels. Expert professionals will help patients choose from a range of options that suit their individual needs. Chapter offers popular aesthetic treatments including HydraFacial®, SkinPen®, DiamondGlow™, custom exfoliating peels, PRP therapy and dermaplane. Body Treatments: Many guests come to Chapter with a concern about their body they want help with — whether it’s stubborn fat on the body, cellulite, lack of energy and fatigue or hair loss. The Chapter team is trained to understand those concerns on a clinical level and, more importantly, on an empathetic level. Chapter offers popular body treatments including CoolSculpting®, CoolTone®, bioidentical hormone replacement therapy, IV therapy and PRP hair restoration. “I couldn’t be more excited about this partnership with ADMI,” said Jennifer Baldwin, Nurse Practitioner and owner of the Chapter Aesthetic Studio New Hartford location. “What this means for our loyal client base is an updated studio look, and elevated resources and technology. What’s not going to change is the warm welcome, friendly faces and top-tier service providers and care practicitioners that our guests know and trust.” Office hours will be Mondays from 9 a.m. to 5 p.m., Tuesdays through Thursdays from 9 a.m. to 7 p.m., Fridays from 9 a.m. to 4 p.m. and Saturdays by appointment only. To make an appointment for a complimentary consultation including dermal imaging, guests can go to www.mychapter.com and click on Book Online; or call 315-737-6230. More information about the New Hartford, NY office and its services can be found here. About Chapter Aesthetic Studio Founder and President Melissa Rogne established Rejuv Medical Aesthetic Clinic in Fargo, North Dakota in 2005. Fueled by her passion for providing innovative aesthetic services and products, Melissa pioneered the region’s aesthetic industry and grew Rejuv to the largest clinic in the Midwest, proudly ranked as an Allergan Top 100 clinic. Melissa is now continuing her mission of empowering everyone to discover their own personal beauty narrative. Rejuv is beginning a new story as Chapter Aesthetic Studio – and we’ll be coming soon to a location near you. We invite you to join our team as we turn the page and reclaim beauty’s one truth: it radiates from within. About Aspen Dental Management, Inc. (ADMI) Aspen Dental Management, Inc. (ADMI) is one of the largest and most trusted retail healthcare business support organizations in the U.S., supporting 15,000 healthcare professionals and team members at more than 1,000 health and wellness offices across 46 states in three distinct categories: Dental care, urgent care, and medical aesthetics. Working in partnership with independent practice owners and clinicians, the team is united by a single purpose: to prove that healthcare can be better and smarter for everyone. ADMI provides a comprehensive suite of centralized business support services that power the impact of four consumer-facing businesses: Aspen Dental, ClearChoice Dental Implant Centers, WellNow Urgent Care and Chapter Aesthetic Studio. Each brand has access to a deep community of experts, tools and resources to grow their practices, and an unwavering commitment to delivering high-quality consumer healthcare experiences at scale. Contact Details Curley Company Lorianne Walker +1 410-688-1330 lorianne@curleycompany.com

September 22, 2021 03:45 PM Eastern Daylight Time

1 ... 254 255 256 257 258 ... 304